Company Update: Actavis plc (NYSE:ACT) – Actavis Announces FDA Approval of NATRELLE INSPIRA™ Round Gel-Filled Textured Breast Implants
June 04, 2015 at 17:17 PM EDT
[PR Newswire] – DUBLIN, June 4, 2015 /PRNewswire/ — Actavis plc (ACT), which recently completed the acquisition of Allergan, Inc., today announced that the company has received approval from the U.S. Food and . . . → Read More: Company Update: Actavis plc (NYSE:ACT) – Actavis Announces FDA Approval of NATRELLE INSPIRA™ Round Gel-Filled Textured Breast Implants Similar Articles: Company Update: Actavis plc (NYSE:ACT) – Actavis cannot drop old version of Alzheimer’s drug – appeals court Company Update (NYSE:ACE): ACE Aviation reports 2014 annual results, announces intent to seek Court approval for a $115 million distribution to shareholders and provides an update on its liquidation process Company Update (NYSE:ACT): (OFFICIAL)-UPDATE 1-Actavis’ superbug antibiotic gets U.S. approval (Feb. 25)
